Document: NUREG-0800
Document ID: 9c7807dc-c665-4c30-84e4-e2cf765872d9
Document Type: srp
Title: and BTP 11-5.  Supporting information on the staff’s evaluation of
Source: NUREG-0800
Source URL: https://www.nrc.gov/docs/ML1307/ML13070A322.pdf
Revision Date: 2023-06
Chapter: 11
Section ID: 11.3
CFR Part: 
CFR Title: 

Content:
ity that would not exceed the SRP dose acceptance criteria due to inhalation and immersion exposure pathways at the EAB. Chapter 16, Section 5.5, “Programs and Manuals,” of the FSAR addresses this commitment in COL applications. The milestones for the development and implementation of such plant- and site--specific requirements are addressed in FSAR Sections 11.5 and 13.4 of COL applications. II. ACCEPTANCE CRITERIA The acceptance criteria, as doses determined at the EAB, remain unchanged from the prior version of BTP 11-5. Compliance with 10 CFR Part 50, Appendix A, GDC 61 was noted in the guidance as it relates to the consequence analyses conducted under SRP Section 11.3 using BTP 11-5. III. REVIEW PROCEDURES The review procedures section was updated in recognition of the revisions identified in the areas of review and acceptance criteria sections, as noted in explanations above. BTP 11-5-1 Draft Revision 4 – July 2014 IV. EVALUATION FINDINGS The evaluation findings section was revised by adding a new subsection. The new subsection discusses the results of the staff’s evaluation and conclusion of acceptability with the guidance of the BTP and its acceptance criteria. The revisions address the following factors: 1. With respect to the consequence analysis addressing the radiological impact from a waste gas system leak or failure, the revision provides more specific guidance on how the staff would confirm that the applicant has provided the results of a site-specific analysis that are consistent with the acceptance criteria of SRP Section 11.3 and BTP 11-5. Supporting information on the staff’s evaluation of the site’s atmospheric dispersion characteristics in dispersing radioactive materials to a dose receptor located at the EAB is presented in SRP Section 2.3.4. 2. If the results of site-specific analyses are not consistent with the BTP acceptance criteria, the staff would confirm that the applicant’s proposed TS limiting the total amounts of